News
Impressive bleeding profile with factor XI inhibitor in AFib: AZALEA
“This gives us real hope that we have finally found an anticoagulant that is remarkably safe,” said Dr. Christian Ruff.
“This gives us real hope that we have finally found an anticoagulant that is remarkably safe,” said Dr. Christian Ruff.
Acamprosate and naltrexone had the highest strength of evidence and were both associated with improvement in drinking outcomes.
Investigators note the findings highlight the importance of monitoring cognitive function in adults with AFib.
RSV disease is a major public health problem among infants younger than age 8 months, causing 100 to 300 deaths annually. In 2023, two new...
Phase 4 trial offers insight into efficacy in patients whose mild cases have gotten less research attention.